PACT and its murine ortholog RAX were originally identified as a protein activator for the dsRNA-dependent, interferon-inducible protein kinase PKR. Recent studies indicated that RAX played a role in embryogenesis and neuronal development. In this study, we investigated the expression of RAX during the postnatal development of the mouse cerebellum and its role in the migration of cerebellar granule neurons (CGNs). High expression of RAX was observed in the cerebellum from postnatal day (PD) 4 to PD9, a period when the CGNs migrate from the external granule layer (EGL) to the internal granule layer (IGL). The migration of the EGL progenitor cells in vivo was inhibited by RAX knockdown on PD4. This finding was confirmed by in vitro studies showing that RAX knockdown impaired the migration of CGNs in cerebellar microexplants. PACT/RAX-regulated migration required its third motif and was independent of PKR. PACT/RAX interacted with focal adhesion kinase (FAK) and PACT/RAX knockdown disturbed the FAK phosphorylation in CGNs. These findings demonstrated a novel function of PACT/RAX in the regulation of neuronal migration. P rotein kinase, interferon-inducible double stranded RNA dependent activator (PACT) and its murine ortholog RAX were independently discovered as the protein activator for the double strand RNA (dsRNA)-dependent, interferon-inducible protein kinase (PKR) 1,2 . PACT and RAX are almost identical in their amino acid sequences and they belong to an evolutionarily conserved family of RNA-binding proteins 3 . Under various stress conditions 4-8 , PACT/RAX binds to PKR through its two dsRNA binding motifs (dsRBMs), and regulates the conformational change of PKR through its third motif, resulting in PKR autophosphorylation 9 and then the phosphorylation of eukaryotic initiation factor 2a (eIF2a), leading to the inhibition of protein synthesis and the induction of apoptosis 10 . PACT also interacts with Dicer to facilitate the maturing process of small RNAs 11,12 . The depletion of PACT affects the accumulation of mature microRNAs (miRNAs) and reduces the efficiency of small interfering RNA (siRNA)-induced RNA interference (RNAi) 13 .
required for its role in migration which is independent of PKR and may be mediated by its interaction with FAK. These results reveal a novel role of PACT/RAX in regulating neuronal migration during the development.
Results
Developmental expression of RAX in mouse cerebellum. To explore the role of PACT/RAX in cerebellar development, we first examined the developmental expression of RAX in mouse cerebellum. High level of RAX was observed in the cerebellum on PD4 and PD9; the expression decreased thereafter ( Figure 1A) . Compared to PD4, the expression of RAX decreased 70%, 86% and 94% by PD15, PD21, and adult, respectively ( Figure 1B) . The immunohistochemical (IHC) staining showed that RAX was highly expressed in EGL and Purkinje cell layer (PL) on PD4 and PD9 ( Figure 1C ), but the RAX-positive cells were only observed in Purkinje cells and interneurons in the internal granule layer (IGL) and molecular layer (ML) at PD15, PD21 and adulthood ( Figure 1C ). Confocal microscope images showed that RAX was expresseed in almost all cells in the EGL of PD4 mouse cerebellum ( Supplementary  Figure 1 ).
Role of RAX in the migration of cerebellar granule neurons (CGNs) in vivo. To explore the function of RAX in the developing cerebellum, the small interfering RNA (siRNA) constructs targeting RAX were delivered to the cerebellar granule precursors in the EGL of PD4 mice by in vivo electroporation. Enhanced yellow fluorescent protein (EYFP) was used as a marker of gene delivery. The RAX siRNA effectively down-regulated the expression of RAX in primary cerebellar granule neurons (CGNs) as determined by immunoblotting and immunofluorescence (Figures 2A and B) . At 48 h post electroporation, some EYFP positive cells were observed migrating from EGL to IGL in the group transfected with a control siRNA; while few EYFP positive cells is migrating in the group transfected with RAX siRNA ( Figure 2C ). In the control group, 49% of the EYFPpositive cells migrated from outer EGL through inner EGL, and traveled through the ML to reach the IGL within 72 hours following the electroporation. However, only 23% of EYFP-positive cells migrated into IGL (Figures 2C and D) in mice treated with RAX siRNA; the migration from the outer EGL to the inner EGL seemed not affected by RAX knockdown (Figures 2C and D) . Also, the migration depth of CGNs was greatly reduced in RAX knockdown mice as compared to control mice; it decreased from 105 mm in control group to 58 mm in RAX knockdown group at 72 hours after the electroporation (Figure 2E ). At 96 hours after the electroporation, more EYFP-positive cells migrated to the IGL; but still fewer migrated cells were observed in mice treated with RAX siRNA ( Figure 2C ). The EYFP-positive cells in the IGL of control mice showed a typical post-migration morphology with multipolar dendrites ( Figure 2F , arrow), while the EYFP-positive cells had a migrating bipolar morphology in the RAX knockdown mice ( Figure 2F , double arrows) 96 hours post the electroporation. At 7 days post electroporation, 93% of the EYFP-positive cells migrated into IGL in the control group, while only 77% of EYFP-positive cells were in IGL in the siRAX group ( Supplementary Figure 2) .
Bergman glia is the migration scaffold for CGNs and displayed no morphological difference in both control and RAX knockdown groups as revealed by GFAP staining ( Figure 3A ). RAX knockdown did not change cell proliferation since the percentage of ki67 positive cells showed no difference between the control siRNA-and RAX siRNA-treated groups (Figures 3B and C). At 7 days post electroporation, the EYFP-positive CGNs migrated into IGL in both groups differentiated and expressed NeuN ( Figure 3D ). We also examined the expression of cleaved caspase-3 and show no difference between control and RAX knockdown groups (data not shown). Taken together, these results suggested that RAX knockdown inhibited the migration of CGNs without affecting the Bergman glia fibers, CGN proliferation/survival and post-migration differentiation.
RAX knockdown inhibits the migration of CGNs in cerebellar microexplants. We further examined the role of RAX in CGN migration by using the cultured cerebellar microexplants from PD6 mice. These mice were transfected with control or siRNA for RAX on PD4. We demonstrated that the migration of CGNs was significantly reduced in RAX knockdown group without apparent morphological alterations. The percentage of neurons that migrated within 100 mm was significantly reduced in RAX knockdown group ( Figures 4A and B ). Neurite growth was not affected by RAX knockdown (Figures 4C and D) . These results supported that RAX played an important role in regulating the migration of CGNs.
The third motif of RAX is essential for its role in regulating CGN migration. RAX is a dsRNA binding protein and has three highly conserved motifs. We generated three recombinant RAX constructs. The first one was a wild type (WT) RAX with synonymous mutation in our siRNA targeting sequence to avoid silencing by the RAX-siRNA. The second one was truncated M1M2 (1-200 aa) including first two dsRBMs with the same mutation; the third one was truncated M3 (201-313 aa) including the third motif ( Figure 5A ). The expression of these constructs was detected by the expression of the Flag-tag ( Figure 5B ). When co-transfected with RAX siRNA, both the WT RAX and M3 constructs alleviated RAX knockdowninduced impairment of CGN migration in the developing cerebellum; however, the M1M2 construct failed to reverse the impairment of CGN migration ( Figure 5C ). These data indicated that the third motif of PACT/RAX was essential for regulating cell migration.
RAX regulation of CGN migration is PKR-independent. PACT/ RAX is the protein activator of PKR and the activation is mediated by the third motif of PACT/RAX 9, 22 . We therefore sought to determine whether RAX regulation of neuronal migration depended on PKR. Up-regulation of PKR did not alleviate RAX knockdown-induced impairment of CGN migration in the developing cerebellum ( Figures 6A and C) . Furthermore, transfection of a dominantnegative PKR (K296R) construct did not aggravate the deficit in migration caused by RAX knockdown (Figures 6B and D) . These results indicated that RAX regulation of CGN migration was independent of PKR.
PACT interacts with FAK and is involved in FAK phosphorylation in CGNs. FAK is an important regulator of cell migration 18, 19 . In neurons, phosphorylation of FAK at serine 732 is critical for the organization of a small network of microtubules which is important for neural migration 20 . We found PACT interacted with FAK by GST pull-down assay ( Figure 7A ) which was also confirmed by coimmunoprecipitation ( Figure 7B ). In addition, RAX knockdown significantly decreased the phosphorylation of FAK at serine 732 in Figure 7E ); 58% of CGNs in the control group displayed prominent perinuclear microtubule cage while only 15% of CGNs transfected with RAX siRNA had this structure ( Figure 7F ).
Discussion
The human protein PACT and its mouse ortholog RAX were discovered independently as the cellular activator for the interferoninducible, dsRNA-dependent protein kinase PKR 1,2 . It has been reported that female flies homozygous for the dRax deletion are sterile 23 , and display defects in CNS development 17 . The deletion of exon 8 of mouse Rax causes developmental defects, including reduced size and severe microtia 14 . The loss of the entire RAX gene in mice induced an early developmental lethality at a pre-implantation stage 17 . These results indicate that RAX plays a role in the embryogenesis and development. In this study, we demonstrate that RAX plays an important role in the development of mouse cerebellum.
High levels of RAX in mouse cerebellum at PD4 and PD9 are consistent with the time period in which CGNs migrate from the EGL to the IGL. Immunohistochemical staining shows that RAX is highly expressed in EGL and Purkinje cells layer, suggesting a role in the migration of CGNs (Figure 1 ). We demonstrate that RAX knockdown causes granule cells to accumulate at the inner border of the EGL where the granule cell migration turns from tangential to radial, and RAX knockdown also affects the distance which granule cells migrate within the IGL (Figure 2 ). However, RAX knockdown does not damage the migration scaffold, the radial fibers of Bergmann glia; it does not affect either the proliferation/survival or differentiation of CGNs (Figure 3 ). It is therefore likely RAX regulates the ability of neuronal migration. This conclusion is supported by an in vitro study showing that RAX knockdown blocks neuronal migration in cultured cerebellar microexplants (Figure 4) .
A recent study shows that PKR is involved in the migration of breast cancer cells; the activation of PKR suppresses cell motility by regulating the p38 MAPK/MK2/LIMK/cofilin pathway 24 . Our results indicate that up-regulation of PKR expression could not rescue RAX knockdown-induced inhibition of CGN migration and co-expression of dominant negative PKR (K296R) does not aggravate the migration defect caused by RAX knockdown (Figure 6 ). Therefore, PACT/RAX regulation of CGN migration is likely independent of PKR.
PACT/RAX contains three independent motifs. The first two resemble dsRBM; the third one consisting of 66 residues appears to be an activator for interacting proteins 22 . The dsRBMs of PACT (motif 1 and 2) interact with the dsRBMs in PKR; but the ability to activate PKR is imparted by the third motif of PACT that binds to the PKR kinase domain 9 . Binding of motif 3 to PKR causes PKR autophosphorylation by converting PKR from inactive conformation to an active one 25 . Although PACT's third motif binds weakly to PKR, it is necessary and sufficient to activate PKR 9 . Motif 1 and 2, on the other hand, may facilitate the process by mediating strong interaction between PACT and PKR. In mammalian cells, PACT itself is phosphorylated during various chemical stresses or growth factor withdrawal, and the phosphorylation may induce conformational changes of PACT to facilitate its third motif to associate with PKR 8, 26, 27 . We demonstrate that the expression of recombinant third motif of RAX is sufficient to reverse the defects in migration caused by RAX knockdown in the developing cerebellum. On the other hand, the expression of other two motifs fails to rescue CGNs from RAX knockdown-induced inhibition of neuronal migration ( Figure 5 ). These results indicate that the third motif of PACT/RAX is critical for its regulation of neuronal migration. Interestingly, it appears that PKR is not involved in this process. Over expression of WT PKR does not alleviate the deficiency of CGN migration caused by RAX knockdown; dominant negative PKR (K296R PKR) is unable to aggravate the deficiency ( Figure 6 ). PKR is not the only protein that interacts with the 3rd domain of PACT/RAX. Other well-known dsRBPs, such as Dicer and trans-activation responsive RNA-binding protein (TRBP), also interact with this domain. There may be other unknown factors that could interact with this domain. Currently, it is unclear how the third motif regulates CGN migration and what its interacting proteins are.
FAK plays an essential role in the regulation of cell migration 18, 19 . By co-IP and GST pull-down assays, we demonstrate the interaction between PACT/RAX and FAK. The phosphorylation of FAK at serine 732 is critical for organization of a small network of microtubules that partially encompass the nucleus which is important for neuronal migration 20, 28 . We show that knockdown of PACT/RAX disturbs phosphorylation of FAK (S732) in CGNs (Figure 7 ). This suggests that PACT/RAX is upstream of FAK which is a critical mediator of neuronal migration.
Hence, our study unravels RAX is a new regulator of CGN migration during cerebellum development. Deficiency of RAX induces CGN migration defects, which is PKR independent, but the third motif of RAX is functionally necessary. Furthermore, knockdown of RAX decreases FAK serine 732 phosphorylation and disrupts the organization of microtubules. This study provides a novel insight into the regulatory mechanism of CGN migration and the potential involvement of RAX in this process. All experimental protocols were approved by Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS). C57BL/6J mice were obtained from Shanghai SLAC Laboratory Animal Co. Ltd (Shanghai, China). The procedure for animal surgery was performed in accordance with the Guideline of Animal Care and Use Committee of the Institute for Nutritional Sciences. Every effort was made to minimize the number of animals used and their suffering.
Plasmids construction and cell transfection. In order to reduce the RAX mRNA level, small hairpin RNAs (shRNA) targeting the RAX sequence were generated using BLOCK-iT TM RNAi designer (Invitrogen Inc., Grand Island, NY). The oligonucleotides specific for the RAX gene were as follows:
1# sense primer: 59-CACCGGACCTTCAGTTTGGGCAAGACGAATCTTGC-CCAAACTGAAGGTCC-39, antisense primer: 59-AAAAGGACCTTCAGTTTGG-GCAAGATTCGTCTTGCCCAAACTGAAGGTCC-39; 2# sense primer: 59-CACCGCAAGATGATAACAGCTAAGCCGAAGCTTAGCTGTTATCATCTTG-C-39, antisense primer: 59-AAAAGCAAGATGATAACAGCTAAGCTTCGGCT-TAGCTGTTATCATCTTGC-39; 3# sense primer: 59-CACCGGAATTAGCAATTCACCATGGCGAACCATGGT-GAATTGCTAATTCC-39, antisense primer: 59-AAAAGGAATTAGCAATTCA-CCATGGTTCGCCATGGTGAATTGCTAATTCC -39. The sense and antisense primers were annealed to generate double-stranded oligonucleotides that were ligated into the pENTR/U6 vector (Invitrogen Inc., Grand Island, NY). A vector containing LacZ targeting sequence was used as a control. DNA constructs were transfected into primary cultured cerebellar granule neurons (CGNs) with electroporation by Amaxa TM Nucleofector TM Technology.
Mouse recombinant RAX with flag-tag was cloned into pCAGGS-IRES-EGFP vector using the primers as follows: FP 59-CCGCTCGAGCTCGCCATGTCCCA-TAGC-39, RP 59-TCCCCCCGGGCTACTTATCGTCGTCATCCTTGTAATCCT-TTCTTTCTGCTATTATCTTTAAATAC-39. Then the synonymous mutation (from 61 TTCAGTTTG 69 to 61 TTTTCACTG 69 ) was generated using KOD -Plus-Mutagenesis Kit (TOYOBO)to avoid silencing by the shRNA plasmid 1# using the primers as follows: FP: 59-GGACAGCGGGACCTTTTCACTGGGCAAGATGAT-AAC-39, RP: 59-GTTATCATCTTGCCCAGTGAAAAGGTCCCGCTGTCC-39. The truncations of RAX were constructed with the mutated template using the primers as follows: M1M2: FP: 59-CCGCTCGAGCTCGCCATGTCCCATAGC-39, RP: 59- Human recombinant GST-PACT fusion protein was cloned into p-GEX-6p-2 vector using the primers as follows: FP 59-CGGGATCCATGTCCCATAGCAGG-CATCG-39, RP 59-CCGCTCGAGCTACTTTCTTTCTGCTATTATCTTTAAA-TACT-39.
Human wild type PKR and dominant negative PKR (K296R) constructs were a kind gift from Dr. Alan Hinnebusch (National Institutes of Health, Bethesda, Maryland). All plasmids were verified by DNA sequencing.
In vivo gene delivery and quantification of CGN migration. Plasmids were delivered to the cerebellum by in vivo electroporation as described previously with some modifications 29, 30 . Briefly, C57BL/6J mouse pups of postnatal day (PD) 4 were anesthetized, and the interparieta bone was exposed and pierced. Plasmids in sterile water containing 0.01% fast green was injected onto the surface of the cerebellum cortex. For each pup, 1.5 ml of plasmid (3 mg/ml) was injected. Electroporation (4 pulses of 100 V for 50 microseconds with 950 microseconds intervals) was carried out using an Electro Square Porator (ECM 830, BTX). These pups were sacrificed 1, 2, 4, or 7 days following electroporation and the cerebella were harvested.
Five slices with highest transfection efficiency from each mouse were selected for quantifying the migration of CGNs. The lobules 4/5 or 6 were examined. We evaluated the percentage of cells that migrated into the IGL as well as the distance that they migrated inside the IGL (depth of migration). The depth of migration was determined by the distance the YFP-positive cell traveled within the IGL.
Culture and analysis of CGNs and cerebellar microexplants. Mouse pups that received in vivo gene deliveries on PD4 were sacrificed 48 hours following the electroporation, and the external granule layer (EGL) containing YFP positive cells was dissected under a dissecting microscope. Some tissues were prepared for primary CGN culture and others were used for cerebellar microexplant culture.
Primary CGN cultures were established as previously described 31 . Briefly, the dissected tissues were dissociated by trypsin incubation and trituration, and then centrifuged. The cell pellet was re-suspended in Neurobasal medium containing B27 (2%), KCl (25 mM), glutamine (1 mM), penicillin (100 units/ml) and streptomycin (100 ug/ml). Cells were plated onto poly-D-lysine (50 mg/ml)-coated coverslips and maintained at 37uC in a humidified environment containing 5% CO 2 for 72 hours. The maximal neurite length in each YFP-positive CGN was measured with Image Pro plus software.
For cerebellar microexplant culture, the tissues were chopped to small pieces which were passed through a 308 mm nylon mesh. The resulting tissue chunks were collected by sedimentation and resuspended in serum-free BME supplemented with hormones as previously described 32 . Cerebellar tissues were plated in coverslips that were double-coated with poly-D-lysine (20 mg/ml in sterile water overnight at room temperature) and laminin (20 mg/ml in PBS for 3 hours at room temperature). After allowing for attachment for 1-2 hours, an appropriate volume of medium (DMEM/ F12 medium with 2 mM glutamine, 0.1 mg/ml BSA, 2.0% N2, 100 units/ml penicillin and 100 mg/ml streptomycin) 33 was added. Explants were cultured for 36 hours, and the rate of CGN migration was measured by the method described previously with some modifications 34 . Briefly, we delimited concentric areas of 0-100, 100-200 or 200-400 mm width from the explant border. The intensity of YFP fluorescence in each area was measured using the Image-Pro Plus software and then expressed as a percentage of YFP intensity of the whole culture.
Immunoprecipitation and immunobloting. Immunoprecipitation of FAK was performed as previously described 35 . Briefly, an aliquot of cell lysate containing 200 mg of proteins was pre-cleared with Protein A/G PLUS-Agarose. Protein A/G PLUS-Agarose was incubated with anti-FAK antibody for 2 hours at 4uC. Then the pre-cleared protein was treated with Protein A/G PLUS-Agarose/antibody complex at 4uC overnight. Immunoprecipitates were collected by centrifugation at 3,000 g for 1 minute. After washing five times with 0.01 M PBS, the pellets were resuspended in 20 ml 2 3 sodium dodecyl sulfate sample buffer. Then the protein sample was analyzed with SDS-PAGE and immunobolting as previously described 31 .
GST pull-down assay. Bacterial cells were lysed using the following buffer: 20 mmol/ L Tris-Cl, 2 mmol/L EDTA, 150 mmol/L NaCl, 0.5% NP40, pH 7.5.The bacterial lysate containing GST-PACT fusion protein was incubated with glutathione-Sepharose 4B beads at 4uC overnight. The beads were washed and then incubated with COS7 cell lysate for 6 hours. After washing, the bound proteins were denatured from the beads and subjected to SDS-PAGE 36 .
Immunohistochemistry. For immunohistochemical analysis, animals were anesthetized by intraperitoneal injection (IP) of chloral hydrate (500 mg/kg) and perfused with 10 ml of saline, followed by 100 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.2) 37 . Then brain tissues were removed and post-fixed in the same fixative overnight then transferred to 30% sucrose for an additional 24 hours and the cerebella were sectioned with a sliding microtome (Microm Laborgerate GmbH, Germany) at the thickness of 25 mm.
The procedure for immunohistochemistry has been previously described 38 . Briefly, cerebellum free-floating sections were incubated in 0.01 M PBS containing 3% H 2 O 2 and 40% methanol for 30 minutes at RT and then treated with 0.5% Triton X-100 (Sigma-Aldrich Co. LLC., St. Louis, MO) in PBS for 5 minutes. The sections were washed with 0.01 M PBS three times and blocked with 1% BSA and 0.05% Triton X-100 for 2 hours at RT and then incubated with primary antibody overnight at 4uC, followed by an incubation with secondary antibody for 2 hours at RT. After three washes in PBS, sections were incubated with Streptavidin, HRP-Conjugated (Calbiochem, Darmstadt, Germany) solutions for 2 hours and then developed in PBS containing 0.05% DAB and 0.003% H 2 O 2 .
Immunofluorescence. Fixed cerebellum sections, microexplants or cultured cells were treated with 0.5% Triton X-100 in PBS for 5 minutes, incubated with blocking solution (1% BSA with 0.05% Triton X-100) for 30 minutes, and then treated with primary antibodies diluted in blocking solution for 1 hour. Cerebellum sections were blocked for 2 hours and then treated with primary antibodies diluted in blocking solution overnight. Sections were then washed with PBS and incubated with the secondary antibody and/or with Alexa FluorH 555 phalloidin for 1 hour. After three washes with PBS, the sections were stained with DAPI. The immunofluorescent images were captured under Zeiss LSM510 meta confocal microscope (Carl Zeiss MicroImaging Inc., Germany).
Statistical analysis. Statistical analyses were performed with PRISM software. Comparisons between two groups were evaluated by the Student's t test. Comparisons among multiple groups were performed with analysis of variance (ANOVA), followed by a two-tailed, unpaired Student's t test. Differences were considered significant when p , 0.05.
